News Focus
News Focus
Post# of 257253
Next 10
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

Re: drbio45 post# 125426

Sunday, 08/21/2011 6:38:29 PM

Sunday, August 21, 2011 6:38:29 PM

Post# of 257253
If a non-substitutable Lovenox knockoff entered the market, MNTA would continue to get a 45% share of NVS’ Lovenox profits, i.e. the same economics as the current arrangement.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now